Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / ADSs
-
Shares outstanding
-
592,878
-
Total 13F shares
-
283,618
-
Share change
-
+61,922
-
Total reported value
-
$1,077,000
-
Price per share
-
$3.79
-
Number of holders
-
17
-
Value change
-
+$263,027
-
Number of buys
-
8
-
Number of sells
-
4
Institutional Holders of Scinai Immunotherapeutics Ltd. - ADSs (BVXV) as of Q1 2021
As of 31 Mar 2021,
Scinai Immunotherapeutics Ltd. - ADSs (BVXV) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
283,618 shares.
The largest 10 holders included
STATE STREET CORP, MORGAN STANLEY, HRT FINANCIAL LP, CITADEL ADVISORS LLC, GOLDMAN SACHS GROUP INC, Virtu Financial LLC, GEODE CAPITAL MANAGEMENT, LLC, TRUE Private Wealth Advisors, TWO SIGMA ADVISERS, LP, and ARK Investment Management LLC.
This page lists
17
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.